JPRN-jRCTs032200263招募中1 期
Confirmation of safety for patients with traumatic brain injury by transcranial direct current stimulation - TDCSTBI
Higuchi Yoshinori0 个研究点目标入组 6 人开始时间: 2020年12月23日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 16age old 至 <= 80age old（—）
- 性别
- All
入选标准
- •1) Patients with a diagnosis of severe brain injury of 8 or less on the Glasgow Coma Scale (GCS) and requiring hospitalization follwoing 1-2 months after the injury.
- •2) Patients whose general condition is stable and who can be safely examined and treated.
- •3) Patients between the ages of 16 and 80 years old at the time of obtaining consent.
- •4) Patients who provide written informed consent based on free will after receiving sufficient explanation for the study. If the patients lack the capacity to consent to participate in the study, the written informed consent will be obtained freely and voluntarily from the delegate.
排除标准
- •1) Patients who are unable to remain at rest
- •2) Patients for whom electrodes cannot be placed.
- •3) Patients with internal metal or electrical devices such as pacemakers or spinal cord stimulators implanted in their bodies.
- •4) Patients who had a seizure within 30 days prior to use of the device.
- •5) Pregnant patients.
- •6) Patients whose examination or treatment is deemed inappropriate by the principal investigator or physician.
研究者
相似试验
已完成
不适用
Improvement of patient safety through a structured team briefing in pediatric anesthesiaPedSOAP-M and device KURZcheck are carried out by the anesthesia team before each anesthesia induction. The results, training of the team, the operating theater and patient risks are collected anonymously. The purpose of the procedure is to increase patient safety through the structured processing of a checklist and patient risks.DRKS00023044Medizinische Hochschule Hannover1,025
已完成
不适用
An Observational Safety Evaluation of patients treated with the NEVO* Sirolimus-eluting Coronary Stent.Coronary Artery Lesions. Ischemia (lack of O2) in the heart muscle due to atherosclerosis/cholesterol10011082NL-OMON36595Johnson & Johnson30
进行中（未招募）
不适用
FIRST-IN-PATIENT STUDY TO ASSESS THE SAFETY AND TOLERABILITY AND TO EXPLORETHE POTENTIAL THERAPEUTIC EFFICACY OF A NOVEL GLUTAMATE MODULATOR ASMONOTHERAPY AND AS ADD-ON THERAPY IN PATIENTS WITH SCHIZOPHRENIA - N/AMedDRA version: 12.1Level: LLTClassification code 10039626Term: SchizophreniaSchizophreniaEUCTR2010-023369-23-ATJanssen-Cilag International NV105
进行中（未招募）
不适用
Investigation of the safety , tolerability and potential therapeutic effects of JNJ-40411813 in patients with schizophreniaSchizophreniaEUCTR2010-023369-23-DEJanssen-Cilag International NV105
进行中（未招募）
不适用
Investigation of the safety , tolerability and potential therapeutic effects of JNJ-40411813 in patients with schizophreniaMedDRA version: 15.0Level: PTClassification code 10039626Term: SchizophreniaSystem Organ Class: 10037175 - Psychiatric disordersSchizophreniaEUCTR2010-023369-23-BGJanssen-Cilag International NV105